These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 25931258)

  • 21. Pretreatment blood neutrophil/lymphocyte ratio is associated with metastasis and predicts survival in patients with pancreatic cancer.
    Guo J; Wu M; Guo L; Zuo Q
    Bull Cancer; 2018 Feb; 105(2):146-154. PubMed ID: 29290332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet to lymphocyte ratio as a novel prognostic tool for gallbladder carcinoma.
    Pang Q; Zhang LQ; Wang RT; Bi JB; Zhang JY; Qu K; Liu SS; Song SD; Xu XS; Wang ZX; Liu C
    World J Gastroenterol; 2015 Jun; 21(21):6675-83. PubMed ID: 26074706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pretreatment platelet and plasma fibrinogen level correlate with tumor progression and metastasis in patients with pancreatic cancer.
    Wang H; Gao J; Bai M; Liu R; Li H; Deng T; Zhou L; Han R; Ge S; Huang D; Ba Y
    Platelets; 2014; 25(5):382-7. PubMed ID: 24001199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A High Monocyte-to-Lymphocyte Ratio Predicts Poor Prognosis in Patients with Advanced Gallbladder Cancer Receiving Chemotherapy.
    Choi YH; Lee JW; Lee SH; Choi JH; Kang J; Lee BS; Paik WH; Ryu JK; Kim YT
    Cancer Epidemiol Biomarkers Prev; 2019 Jun; 28(6):1045-1051. PubMed ID: 30842131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pretreatment lymphocyte-monocyte ratio as a potential prognostic factor in a cohort of patients with upper tract urothelial carcinoma.
    Hutterer GC; Sobolev N; Ehrlich GC; Gutschi T; Stojakovic T; Mannweiler S; Pummer K; Zigeuner R; Pichler M; Dalpiaz O
    J Clin Pathol; 2015 May; 68(5):351-5. PubMed ID: 25661796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of preoperative platelet/lymphocyte and neutrophil/lymphocyte rates and tumor-related factors to predict lymph node metastasis in patients with gastric cancer.
    Pang W; Lou N; Jin C; Hu C; Arvine C; Zhu G; Shen X
    Eur J Gastroenterol Hepatol; 2016 May; 28(5):493-502. PubMed ID: 26854795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of pretreatment inflammatory biomarkers in advanced lung adenocarcinoma patients receiving first-line pemetrexed/platinum doublet.
    Xiong Y; Zhao N; Zheng Y; Wang J; Wei F; Ren X
    Tumour Biol; 2017 Jun; 39(6):1010428317701639. PubMed ID: 28618954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum CA 19-9 response to neoadjuvant therapy is associated with outcome in pancreatic adenocarcinoma.
    Boone BA; Steve J; Zenati MS; Hogg ME; Singhi AD; Bartlett DL; Zureikat AH; Bahary N; Zeh HJ
    Ann Surg Oncol; 2014 Dec; 21(13):4351-8. PubMed ID: 25092157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The preoperative plasma fibrinogen level is an independent prognostic factor for overall survival of breast cancer patients who underwent surgical treatment.
    Wen J; Yang Y; Ye F; Huang X; Li S; Wang Q; Xie X
    Breast; 2015 Dec; 24(6):745-50. PubMed ID: 26482138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum lactate dehydrogenase predicts prognosis and correlates with systemic inflammatory response in patients with advanced pancreatic cancer after gemcitabine-based chemotherapy.
    Yu SL; Xu LT; Qi Q; Geng YW; Chen H; Meng ZQ; Wang P; Chen Z
    Sci Rep; 2017 Mar; 7():45194. PubMed ID: 28345594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Patients with Unresectable Hepatocellular Carcinoma Treated with Radioembolization.
    Sukato DC; Tohme S; Chalhoub D; Han K; Zajko A; Amesur N; Orons P; Marsh JW; Geller DA; Tsung A
    J Vasc Interv Radiol; 2015 Jun; 26(6):816-24.e1. PubMed ID: 25824315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
    JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CA19-9 in potentially resectable pancreatic cancer: perspective to adjust surgical and perioperative therapy.
    Hartwig W; Strobel O; Hinz U; Fritz S; Hackert T; Roth C; Büchler MW; Werner J
    Ann Surg Oncol; 2013 Jul; 20(7):2188-96. PubMed ID: 23247983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined preoperative platelet-to-lymphocyte ratio and serum carbohydrate antigen 19-9 level as a prognostic factor in patients with resected pancreatic cancer.
    Sakamoto T; Saito H; Amisaki M; Tokuyasu N; Honjo S; Fujiwara Y
    Hepatobiliary Pancreat Dis Int; 2019 Jun; 18(3):278-284. PubMed ID: 30987900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low lymphocyte monocyte ratio after neoadjuvant therapy predicts poor survival after pancreatectomy in patients with borderline resectable pancreatic cancer.
    Kawai M; Hirono S; Okada KI; Miyazawa M; Shimizu A; Kitahata Y; Kobayashi R; Ueno M; Hayami S; Tanioka K; Yamaue H
    Surgery; 2019 Jun; 165(6):1151-1160. PubMed ID: 30765142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A nomogram based on preoperative inflammatory markers predicting the overall survival of pancreatic ductal adenocarcinoma.
    Xu J; Shi KQ; Chen BC; Huang ZP; Lu FY; Zhou MT
    J Gastroenterol Hepatol; 2017 Jul; 32(7):1394-1402. PubMed ID: 27973703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood neutrophil-lymphocyte ratio predicts survival in patients with advanced pancreatic cancer treated with chemotherapy.
    Luo G; Guo M; Liu Z; Xiao Z; Jin K; Long J; Liu L; Liu C; Xu J; Ni Q; Yu X
    Ann Surg Oncol; 2015 Feb; 22(2):670-6. PubMed ID: 25155401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive Comparative Analysis of Prognostic Value of Systemic Inflammatory Biomarkers for Patients with Stage II/III Colon Cancer.
    Suzuki S; Akiyoshi T; Oba K; Otsuka F; Tominaga T; Nagasaki T; Fukunaga Y; Ueno M
    Ann Surg Oncol; 2020 Mar; 27(3):844-852. PubMed ID: 31720937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of neutrophil to lymphocyte ratio in patients with gallbladder carcinoma.
    Zhang L; Wang R; Chen W; Xu X; Dong S; Fan H; Liu C
    HPB (Oxford); 2016 Jul; 18(7):600-7. PubMed ID: 27346141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The metastasis status and tumor burden-associated CA125 level combined with the CD4/CD8 ratio predicts the prognosis of patients with advanced pancreatic cancer: A new scoring system.
    Yang C; Cheng H; Luo G; Lu Y; Guo M; Jin K; Wang Z; Yu X; Liu C
    Eur J Surg Oncol; 2017 Nov; 43(11):2112-2118. PubMed ID: 28802662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.